Featured
Health Topics
Any CategoryPsychiatry and Psychology
-
- Anxiety Disorders 11
- Bipolar and Related Disorders 1
- Disruptive, Impulse Control, and Conduct Disorders 1
- Elimination Disorders 1
- Mood Disorders 10
- Neurocognitive Disorders 3
- Neurodevelopmental Disorders 11
- Personality Disorders 3
- Schizophrenia Spectrum and Other Psychotic Disorders 2
- Sleep Wake Disorders 4
- Somatoform Disorders 1
- Substance-Related Disorders 26
- Trauma and Stressor Related Disorders 4
Search Clinical Trials
Completed
Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep (External Link)
Alcohol is one of the most popular substances used worldwide for thousands of years. Globally, harmful alcohol use continues to be a major public health and economic burden. The World …
Baylor Role:
Lead Sponsor
Completed
Genetic Inclusion by Virtual Evaluation (External Link)
Inadequate access to genetics evaluation and genomic testing in the Hispanic minorities living along the Texas-Mexico has marginalized the most vulnerable pediatric group. In this study, we will (1) implement …
Baylor Role:
Lead Sponsor
Completed
Expanding Reach of Evidence-based Psychotherapy for Veterans With Co-occurring Anxiety and Substance Use Disorders. (External Link)
The current study seeks to better understand how to improve access to evidence-based psychotherapy (EBP) for rural Veterans with co-occurring anxiety and substance use disorders (SUD) using a web-based cognitive …
Baylor Role:
Lead Sponsor
Completed
Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD (External Link)
Autism spectrum disorder, or ASD, is one of the most common neurodevelopmental disorders, affecting up to 1 out of 59 youth in the United States. Anxiety disorders affect 50-80% of …
Baylor Role:
Lead Sponsor
Completed
Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study) (External Link)
This study can be classified as a phase 1, single center, and drug-drug interaction (DDI) study. The within-subjects' experimental procedures will assess pharmacokinetic interactions between ethanol (EtOH) and PT150 (900 …
Baylor Role:
Collaborator
Completed
Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder (External Link)
Anxiety and obsessive-compulsive disorders are the most common mental health disorders in childhood and adolescence. Parental accommodation of their children's avoidance, escape, safety behaviors are a set of parenting behaviors …
Baylor Role:
Lead Sponsor
Completed
Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder (External Link)
More treatments are needed to target insomnia in Veterans with Posttraumatic Stress Disorder. There is evidence to suggest that pimavanserin, a medication approved by the Food and Drug Administration for …
Baylor Role:
Lead Sponsor
Completed
Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD (External Link)
Anxiety disorders affect 50-80% of children with autism spectrum disorder (ASD) and are associated with significant life impairment and worsening trajectory without treatment. The most effective psychotherapy for anxiety in …
Baylor Role:
Lead Sponsor
Completed
Peer-led Group Intervention for Coping With Disaster (External Link)
Approximately 20% of individuals have significant behavioral health concerns. Exposure to a disaster like Hurricane Harvey and its aftermath often exacerbates pre-existing issues and/or brings new issues, with post-traumatic stress …
Baylor Role:
Lead Sponsor
Completed
Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal (External Link)
This study is a Phase 2A, randomized, double-blinded, placebo-controlled, two-period crossover study to evaluate the effect of two doses of SXC-2023 on measures of impulsivity and inhibitory control, urge for …
Baylor Role:
Collaborator